Any current/future new fundraising through debt or equity?

Inditrade Capital is actively working with multiple PSU banks and institutions to access new borrowing, especially for microfinance growth, having just completed a three-year track record required by PSU banks. The company recently secured a working capital loan from SIDBI at a favorable rate and is exploring loans from other organizations like NABARD. They aim to shift the borrowing mix from 85% NBFC and 15% banks to about 50:50, which should reduce the cost of funds significantly. No mention of immediate equity fundraising is made; focus is on debt and improving borrowing costs. They plan to

Any current/future capex/capital investment/strategic investment?

No significant capital expenditure planned for insurance broking segment as of August 2020; branches and infrastructure are already in place. Insurance broking business expansion focused on ramping up retail piece, leveraging existing branches without further capital outlay. Insurance broking not capital-intensive; no new branch openings required, thus no further capital expenditure expected. Acquisition of Sistema Business Scalerator team onboarded, but no company/assets/liabilities acquired; fits into an existing idle subsidiary. Changing the name and business object of the subsidiary to ref

Future growth expectations in sales/revenue/volumes?

Insurance broking segment: Expecting a significant pickup in the latter half of 2020 after COVID disruptions, with no further capital expenditure planned as branches are set up. Synergies with other segments via mandatory insurance for microfinance and MSME customers are strong. Hopeful to start earning significant revenue by year-end. Microfinance: Targeting reduction in cost of funds by increasing borrowing from PSU banks, aiming to reduce interest cost from 14.88% to around 12% within a year and potentially further in two years, which would support growth. Disbursements to restart in stab

Future growth expectations in earnings/operating earnings/profits/EPS?

Inditrade Capital aims to ramp up its insurance broking business, expecting significant volume growth in the latter half of 2020 due to increased insurance demand post-COVID. Cost of funds is expected to reduce, especially in microfinance, with a target to bring the borrowing cost down from 14.88% to around 12% within a year, and possibly lower in two years, improving margins. Agri and MSME lending rates are also expected to decline, potentially leading to improved profitability in these segments. The company has controlled expenses significantly despite COVID challenges and acquired a n

Inditrade Capital LtdQ1 FY21Finance

Inditrade Capital Ltd Q1 FY21 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹2.51Market Cap: ₹6 CrSector: Finance

Management growth scorecard

Revenue

Category 4

Margin

Category 2

Fundraise

Yes

Order

N/A

Capex

1 of 4 growth signals are positive — mixed outlook.

Full analysis

Revenue guidance

Category 4

Insurance broking segment: Expecting a significant pickup in the latter half of 2020 after COVID disruptions, with no further capital expenditure planned as branches are set up. Synergies with other segments via mandatory insurance for microfinance and MSME customers are strong. Hopeful to start earning significant revenue by year-end.
Microfinance: Targeting reduction in cost of funds by increasing borrowing from PSU banks, aiming to reduce interest cost from 14.88% to around 12% within a year and potentially further in two years, which would support growth. Disbursements to restart in stable regions like Karnataka, with cautious calibrated lending.
MSME and Agri segments: Interest rates and borrowing costs expected to decrease (Agri rates from 9.56% to approx. 8-8.5%, MSME below 10%), supporting better growth. Agri business disbursing loans continuously with good margins due to favorable commodity prices.
New team from Sistema acquisition to enhance distribution in South India, operating across 306 towns, expected to contribute to growth in distribution of financial products.
Overall growth is cautiously optimistic, dependent on economic recovery and easing of COVID-related disruptions.

Margin guidance

Category 2

Inditrade Capital aims to ramp up its insurance broking business, expecting significant volume growth in the latter half of 2020 due to increased insurance demand post-COVID.
Cost of funds is expected to reduce, especially in microfinance, with a target to bring the borrowing cost down from 14.88% to around 12% within a year, and possibly lower in two years, improving margins.
Agri and MSME lending rates are also expected to decline, potentially leading to improved profitability in these segments.
The company has controlled expenses significantly despite COVID challenges and acquired a new distribution team (Sistema), which is expected to be cash breakeven by December, contributing positively going forward.
Management is cautiously optimistic to improve earnings and EPS with an expected uptick in disbursements and collections in H2 FY21.
No further capital expenditure planned, reducing financial strain on profitability.
Overall, Inditrade expects a gradual return to growth and better profitability supported by diversified segments and operational efficiencies.

See what Inditrade Capital Ltd management said on margin guidance — free account, 30 seconds.

Fundraise plans

Yes

Inditrade Capital is actively working with multiple PSU banks and institutions to access new borrowing, especially for microfinance growth, having just completed a three-year track record required by PSU banks.
The company recently secured a working capital loan from SIDBI at a favorable rate and is exploring loans from other organizations like NABARD.
They aim to shift the borrowing mix from 85% NBFC and 15% banks to about 50:50, which should reduce the cost of funds significantly.
No mention of immediate equity fundraising is made; focus is on debt and improving borrowing costs.
They plan to build a "war chest" by increasing borrowings while cash flows remain comfortable, preparing to lend aggressively once market conditions stabilize.

Order book

The transcript of the Inditrade Capital Limited Q1 FY’21 earnings call dated August 7, 2020, does not specifically mention current or expected order book or pending orders. Key points related to business outlook include: - Focus remains on microfinance, MSME finance, micro-lending, and agri commodity finance. - AUM stands at INR 450 crores with a balance sheet size of INR 479 crores as of June 30, 2020. - Disbursements have been minimal due to COVID-19, except for some in agri and micro-loan segments. - Agri business disbursements are ongoing and expected to grow due to favorable market conditions. - Microfinance and MSME disbursements are subdued but expected to improve as collections normalize. - The company is building a war chest by borrowing now to be ready for lending when market conditions improve. No direct information on order book size or pending orders was disclosed.

See what Inditrade Capital Ltd management said on order book — free account, 30 seconds.

Capex plans

No significant capital expenditure planned for insurance broking segment as of August 2020; branches and infrastructure are already in place.
Insurance broking business expansion focused on ramping up retail piece, leveraging existing branches without further capital outlay.
Insurance broking not capital-intensive; no new branch openings required, thus no further capital expenditure expected.
Acquisition of Sistema Business Scalerator team onboarded, but no company/assets/liabilities acquired; fits into an existing idle subsidiary.
Changing the name and business object of the subsidiary to reflect distribution of third-party products (including Inditrade’s) - likely minimal capex.
Overall, no major capital commitments; focus is on operational leverage and synergy realization rather than capital investment.
Working capital loans and funding are being managed through borrowings, with no mention of new strategic capital investments.

Track Inditrade Capital Ltd — get its next earnings analysis in your feed

How does Inditrade Capital Ltd rank vs peers in Finance?

Pro feature

ThisInditrade Capital Ltd

Rev 4Mar 2

See where Inditrade Capital Ltd sits in FinanceSee which companies these are, and every other name in the sector.Open rankings

How does Inditrade Capital Ltd rank in Finance?

Compare Inditrade Capital Ltd against every Finance company (Q1 FY21) on revenue, margins and earnings-call signals.

View Finance leaderboard →

What Inditrade Capital Ltd's management said in earlier quarters

Others in Finance this season

Industrial Investment Trust Ltd (Q2 FY27)
Revenue from Operations (Standalone) for Q2 Sept 30, 2026: ₹1,078.16 lakhs, vs. Key results statement takeaways from Industrial Investment Trust Ltd's Q2 FY27 e
MASK INVESTMENTS (Q2 FY27)
The Cash Flow Statement (page 6) shows a significant decrease in unsecured loans by ₹27.65 lakhs during the half year ended 30th September 2026, indicating…
Muthoot Finance Ltd (Q2 FY27)
Total Income: ₹100,108 Mn (up 36% YoY from ₹72,990 Mn) . Key investor presentation takeaways from Muthoot Finance Ltd's Q2 FY27 investor presentation — and how
Nahar Capital & Financial Services Ltd (Q2 FY27)
1,305.36 lakhs implies an operating margin of approximately 84.5% (1,305.36 / 1,544.82) . Key results statement takeaways from Nahar Capital & Financial Service

Compare:vs Bajaj Finance vs Bajaj Finserv vs Shriram Finance Ltd

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →